Paravertebral Block vs. Suprascapular Block for Treatment of Frozen Shoulder
NCT ID: NCT04709874
Last Updated: 2022-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2022-01-02
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: The primary objective of this study is to compare the effectiveness of nerve stimulator guided paravertebral block versus suprascapular block for treatment of frozen shoulder. The primary outcome is pain measured through the Visual Analogue Scale (VAS) over a follow up period of 6 months.
Methods: This is a prospective randomized clinical trial that will be conducted between February 2021 and January 2022. Patients will be randomly allocated into two groups. Group I will receive paravertebral block guided by a nerve stimulator. Group II patients will receive suprascapular nerve block. Patients will be followed up at week 1, month 1, month 3 and month 6.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frozen Shoulder (Scapular Mobilization Versus Scapular PNF)
NCT06201468
Frozen Shoulder Single Arm Prospective Study
NCT04687735
Frozen Shoulder Treatment with Intra-Articular Corticosteroid Injection and Suprascapular Nerve Block
NCT06229964
Scapular Mobilization Versus Capsular Stretch
NCT06705426
Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy
NCT07016386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Paravertebral block
Patients will receive paravertebral block guided by a nerve stimulator.
Paravertebral block
Paravertebral block using nerve stimulator guidance will be done at C7-T1
Suprascapular block
Patients will receive suprascapular block
Suprascapular block
Paravertebral block using nerve stimulator guidance will be done
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paravertebral block
Paravertebral block using nerve stimulator guidance will be done at C7-T1
Suprascapular block
Paravertebral block using nerve stimulator guidance will be done
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presenting with frozen shoulder and were unresponsive to conservative therapy
Exclusion Criteria
* Osteoarthritis
* Calcified tendinitis
* History of shoulder joint injury
* Cervical radiculopathy
* Bleeding disorder
* Active infection
* Allergy to Bupivacaine
* Diabetes Mellitus
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Makassed General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zoher Naja
Anesthiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoher Naja, MD
Role: PRINCIPAL_INVESTIGATOR
Makassed General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Makassed General Hospital
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11012021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.